Post-Brexit U.K. is a unique trade jurisdiction – not EU, not U.S., not CPTPP. UK exporters face Section 122 plus base MFN. Section 232 pharma effective July 31 affects branded UK pharma (AstraZeneca, etc.). Whisky tariff scenarios remain politically sensitive. We model UK exporter exposure across multiple scenarios.
This guide covers Brexit US-UK Trade Consultant. Strategic tariff work spans sourcing decisions, scenario planning, and supply chain design.
Practical implementation depends on company size, sector, and operational structure.
Post-Brexit U.K. trade status
Independent of EU. No comprehensive U.S.-U.K. FTA. Section 122 + base MFN typical.
Section 232 pharma exposure
AstraZeneca, GSK, U.K.-based specialty pharma face Section 232 on branded products effective July 31.
Whisky tariff scenarios
Politically sensitive. Currently MFN + Section 122. Scotch Whisky Association closely monitors.
Routing via Canada
CETA preferential into Canada then USMCA-eligible into U.S. (with substantial transformation in Canada). Limited applicability for U.K. luxury and pharma.
Frequently asked questions
When does this apply?
Most relevant for SMB importers facing the named situation or considering the named strategy.
What documentation is needed?
Standard CBP forms plus topic-specific records.
What is the timeline?
Initial assessment 2-4 weeks; complex implementation 8-16 weeks.
What does this cost?
Project work typically $5,000-$25,000. Ongoing retainer for active operations.
How do I begin?
Book a 15-minute scoping call. We confirm fit before any engagement.
Get started
Engage on supply chain or strategy work. Project pricing varies by scope.